Sort
326,823 grants matching “clinical trial”
Infectious Diseases Fellowship Program
$1,663,696Christa Zerbe · National Institute Of Allergy And Infectious Diseases · ZIE · FY2021 · AI
Therapeutic Targeting of Carotid Body Chemoreflex for Sleep Disordered Breathing
$1,663,662Nanduri R Prabhakar · University Of Chicago · UH2 · FY2014 · HL
Yale Alzheimer Disease Research Center
$1,663,561Stephen M Strittmatter · Yale University · P50 · FY2015 · AG
ANCA Glomerulonephritis: From Molecules to Man
$1,663,528Ronald J Falk · Univ Of North Carolina Chapel Hill · P01 · FY2016 · DK
The National Institute on Aging (NIA) Late Onset of Alzheimer's Disease (LOAD) Family-Based Study (FBS)
$1,663,171Richard Mayeux · Columbia University Health Sciences · U24 · FY2021 · AG
National Institute of Arthritis and Musculoskeletal and Skin Diseases Clinical Studies Management and Support
$1,663,142Kathy Dimeo · Kai Research, Inc · N01 · FY2018 · HL
HIV VACCINE CLINICAL TRIAL UNIT AT SAINT LOUIS UNIVER
$1,663,021Saint Louis University · U01 · FY2001 · AI
rAAV-CNGB3 Gene Therapy for Achromatopsia: Translational Research Studies
$1,663,014William W Hauswirth · University Of Florida · R24 · FY2016 · EY
SOFT TISSUE SARCOMA PROGRAM PROJECT
$1,662,853Sloan-Kettering Institute For Cancer Res · P01 · FY2001 · CA
BABY HUG FOLLOW-UP STUDY II: DATA COORDINATING CENTER
$1,662,833Susan Assmann · New England Research Institutes, Inc. · N01 · FY2016 · HL
Integrating NK and DC into Cancer Therapy
$1,662,647Michael T Lotze · University Of Pittsburgh At Pittsburgh · P01 · FY2009 · CA
Penn Center for Study of Epigenetics in Reproduction
$1,662,589Marisa S. Bartolomei · University Of Pennsylvania · U54 · FY2012 · HD
Delaware Christiana Care NCORP
$1,662,450Gregory A Masters · Christiana Care Health Services, Inc. · UG1 · FY2021 · CA
Modulation of Muscle Growth for the Muscular Dystrophies
$1,662,366University Of Pennsylvania · U54 · FY2005 · AR
Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations.
$1,662,325Lori Ann Orlando · Duke University · U01 · FY2020 · HG
Preclinical Development of an Anti-Mucus Drug
$1,662,288Michael Jay Holtzman · Washington University · UH3 · FY2018 · HL
Phase II Trial of Lonafarnib, Pravastatin and Zoledronic Acid in Progeria
$1,662,201Mark W Kieran · Dana-Farber Cancer Inst · RC2 · FY2009 · HL
Clinical and Laboratory Studies of Malignant Lymphomas
$1,662,201Ronald Levy · Stanford University · P01 · FY2007 · CA
Ocular hypertension treatment study (OHTS)
$1,661,975Washington University · U10 · FY2004 · EY
ALZHEIMER DISEASE RESEARCH CENTER
$1,661,939University Of Southern California · P50 · FY2001 · AG
Energetics & Breast Cancer: Obesity, Inflammation, Insulin Resistance & Risk
$1,661,926Ruth E Patterson · University Of California, San Diego · U54 · FY2014 · CA
Hereditary Muscle Disease Unit
$1,661,885Ami Mankodi · National Institute Of Neurological Disorders And Stroke · ZIA · FY2018 · NS
Production Development
$1,661,879Niranjan Y Sardesai · Wistar Institute · U19 · FY2019 · AI
Women's Health Study: Continued Follow-up
$1,661,840Brigham And Women'S Hospital · R01 · FY2005 · CA
Functional Selectivity: A Novel Approach for CNS Drug Discovery
$1,661,716Bryan L Roth · Univ Of North Carolina Chapel Hill · U19 · FY2012 · MH